RecruitingNot Applicable

BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment

Spain25 participantsStarted 2024-06-27

Plain-language summary

1. To establish the correlation between the evolution of the body mass index in benign intracranial hypertension and the response to treatments. 2. To establish the BMI at which this disease occurs. 3. To establish how much the BMI must be reduced to cure this disease. 4. To assess the evolution and response to treatments of sick people who DO NOT reduce or even continue to increase their BMI despite treatment with Acetazolamide or a possible CSF diversion

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18 years and older at the time of enrollment. There is no upper age limit to ensure inclusivity across age ranges. * A confirmed diagnosis of Idiopathic Intracranial Hypertension, established according to the Dandy criteria. * The diagnostic process must exclude other potential causes of increased intracranial pressure as detailed in the 'Diagnosis' section, ensuring an accurate identification of idiopathic cases. Exclusion Criteria: * A diagnosis other than IIH, specifically: tension-type headache, Chiari I malformation, or any other headache disorder unrelated to IIH. * The presence of secondary causes of increased intracranial pressure (e.g., structural brain abnormalities, venous sinus thrombosis, or medication-induced factors).

What they're measuring

Response to treatment

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT06913712

SponsorUniversity of Valencia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-05-01

Contact for this trial

Vicente Vanaclocha, Professor

+ 34 963 13 18 00 vivava@uv.es